Radiation recall pneumonitis induced by chemotherapy after thoracic radiotherapy for lung cancer

Radiation Oncology

Table 3 Characteristics of the 12 RRP cases

Patient	Consolidation chemotherapy	Time interval between end of RT and RRP (days)	Time interval between end of RT and beginning of ChT (days)	Time interval between beginning of ChT and RRP (days)	Fever	Cough Grade	Grade of shortness of breath	RRP Grade	Rechallenge	Time interval between RRP and rechallenge (days)
1	CEV×2	71	42	29	<38°C	2	2	2	No
2	D×1	82	31	51	<38°C	3	0	3	No
3	GD×1	81	59	22	<38°C	0	0	2	GD	14
4	CE×4	94	15	79	No	2	0	2	P	89
5	NP×2	102	60	42	<38°C	0	2	2	No
6	PC×2	86	46	40	<38.5°C	2	2	2	D	85
7	GD×2	94	56	38	<38°C	0	0	2	GD	20
8	PC×1	95	59	36	<38°C	2	0	2	PC	20
9	PC×2	105	34	71	No	2	2	2	NP	73
10	PC×2	118	41	77	<38°C	1	2	2	No
11	EP×4	171	7	164	No	2	0	2	GI	4
12	PC×3	202	31	169	<38°C	2	0	2	No

RRP indicates radiation recall pneumonitis; CEV, cyclophosphamide, epirubicin, vincristine; D, docetaxel; GD, gemcitabine, docetaxel; CE, carboplatin, etoposide; NP, navelbine, cisplatin; PC, paclitaxel, carboplatin; EP, etoposide, cisplatin; RT, radiotherapy; ChT, chemotherapy; P, paclitaxel; GI, gemcitabine, ifosfamide.

ISSN: 1748-717X